The CBI has filed an indictment in an alleged corruption case in which a senior Central Drugs Standard Control Organization (CDSCO) official and a Biocon Biologics executive were arrested in June this year, officials said.
It is alleged that the payment of bribes of Rs nine lakh to Joint Drug Controller S Eswara Reddy was authorized by Associate Vice President of Biocon Biologics L Praveen Kumar, they said.
The bribe was allegedly for favorably recommending the insulin aspart injection case at the May 18 Expert Committee (SEC) meeting to forgo the Phase 3 clinical trial, they said. declared.
The agency had filed an indictment on August 18, they said.
In a coordinated operation, the CBI had arrested Reddy, Kumar, Dinesh Dua, director of Synergy Network India Private Limited, who allegedly gave the bribe to Reddy, Guljit Sethi, an alleged conduit of Biocon Biologics, as well as the Deputy Drug Inspector Animesh Kumar. in the case.
Biocon Biologics, a subsidiary of Biocon headed by Kiran Mazumdar Shaw, however, denied the corruption allegations.
“We deny corruption allegations made in certain media articles. All of our product endorsements are legitimate and supported by scientific and clinical data. Our bAspart is approved in Europe and many other countries,” the spokesperson had said.
“We follow the regulatory process for all our product approvals by DCGI (Drugs Controller General of India). The entire application process in India is online and all meeting minutes are in the public domain. We are cooperating with the investigative agency,” the spokesperson said.
(Only the title and image of this report may have been edited by Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)